Centers of Excellence
The Latest Research on Bladder Health
From the Editor
From the Desk of the Editor - “Discouraged patients, frustrated clinician!”
I want to share with you the story of my approach to two of my patients being seen for overactive bladder symptoms of urgency and frequency during the day and night. I thought you might be interested in their stories as what I found to be successful treatments were not an approach often recommended. Their symptoms had defied most treatments.
The first patient was James, a 74-year-old man who was referred for Percutaneous tibial nerve stimulation (PTNS) treatments, having failed 2 injections of Botox and multiple overactive bladder (OAB) medications. He had refused an Interstim implant. James was tolerating his
Diane K. Newman, DNP, ANP-BC, FAAN
Diane K. Newman, DNP, ANP-BC, FAAN is an Adjunct Professor of Urology in Surgery, Perelman School of Medicine, University of Pennsylvania. She is Co-Director of the Penn Center for Continence and Pelvic Health, Division of Urology, University of Pennsylvania Medical Center, in Philadelphia. She completed her masters in nursing at the University of Pennsylvania and the Doctorate of Nursing Practice at Thomas Jefferson University, both in Philadelphia. Dr Newman is a clinician and researcher. She has over 30 years’ experience practicing as a urology nurse practitioner. Her practice involves the evaluation, treatment, and management of urinary incontinence including the use of biofeedback for pelvic floor disorders and catheters and other devices in the management of bladder dysfunction. She has expertise in clinical trials and patient reported outcome measures as well as, incorporating patient preferences and beliefs into clinical decision making. She is the author of several books. The most recent is as lead editor of the 1st edition of the Society of Urologic Nurses and Associates Core Curriculum for Urologic Nursing and of Clinical Application of Urologic Catheters, Devices and Products.
AUA 2018 Lower Urinary Tract Conditions – Nocturia
- AUA 2018: A Prospective Study to Evaluate Efficacy with the Nuro™ Percutaneous Tibial Neuromodulation System in Drug Naïve Patients with Overactive Bladder Syndrome May 21, 2018
- AUA 2018: Association Between Overactive Bladder Severity and Bold fMRI Brain Activity May 21, 2018
- AUA 2018: Noctiva: Addressing a Nighttime Condition with Daytime Consequences May 20, 2018
- AUA 2018: Clinical Evaluation and Treatment of Nocturia is Modest at Best May 19, 2018
- AUA 2018: What’s Keeping You Up at Night? Nocturia as a Primary Complaint May 19, 2018
- AUA 2018: Advances in Diagnosis & Management in Nocturia May 19, 2018
SUFU WM 2018
- SUFU 2018: The Effects of Augmentation Cystoplasty and Botulinum Toxin Use on Patient Reported Bladder Function March 4, 2018
- SUFU 2018: Randomized Controlled Trial of Group-Administered Behavioral Treatment in Reducing Urinary Incontinence in Adult Women March 4, 2018
- SUFU 2018: A Novel Sacral Neuromodulation Infection Protocol is Associated with Reduction in Device Infection March 3, 2018
- SUFU 2018: Safety and Efficacy of Onabotulinumtoxina Injections in Octo and Nonagenarians March 2, 2018
- SUFU 2018: Management of Nocturia March 2, 2018
- SUFU 2018: Clinical Experience with Posterior Tibial Nerve Stimulation in the Elderly March 2, 2018
- SUFU 2018: Pathophysiology of Nocturia March 2, 2018
- SUFU 2018: 5 Year Results of The Prostatic Urethral LIFT Pivotal Study March 2, 2018
- SUFU 2018: Management of Stress Urinary Incontinence in the Female Underactive Bladder March 2, 2018
- SUFU 2018: The Pathophysiology and Future of Underactive Bladder March 2, 2018
- SUFU 2018: Management of LUTS in the Male Underactive Bladder March 2, 2018
- SUFU 2018: AUA/SUFU SUI Guidelines March 1, 2018
- SUFU 2018: Effect of Age on Outcomes Of Transvaginal Native Tissue Repairs for Apical Vaginal Prolapse March 1, 2018
AUA 2017 Prostate Cancer
AUA 2017 Press Releases
- Velicept Therapeutics Initiates First of Two Phase 2b Dose-Ranging Studies of Solabegron in Patients with Overactive Bladder; Finalizes Novel, Once Daily Formulation; and Receives U.S. Patent Covering OAB
- New Data Demonstrating Enobosarm’s Potential to Treat Stress Urinary Incontinence -Presented at SUFU 2018.
- Association of Pharmacologic Treatment of Urgency Urinary Incontinence With Sleep Quality and Daytime Sleepiness.
- Sleep Quality and Daytime Sleepiness Among Women With Urgency Predominant Urinary Incontinence.